UK Government Invests £82.6 Million in AI-Driven Cancer Research
UK invests £82.6 million in AI cancer research. Three projects aim to enhance diagnostics and drug discovery. 🧬💰
Antiviral therapy can effectively suppress irAEs in HBV positive hepatocellular carcinoma treated with ICIs: validation based on multi machine learning.
Antiviral therapy reduces immune-related adverse events in HBV-positive liver cancer patients treated with immunotherapy. 📉💊
Advancements in AI for Tailored Cancer Treatments
AI enhances personalized cancer treatment by analyzing diverse patient data, improving prognosis accuracy and clinical decision-making. 🧬🤖
Development of a deep learning system for predicting biochemical recurrence in prostate cancer.
A deep learning system predicts biochemical recurrence in prostate cancer, enhancing treatment strategies. 🤖📊 Promising results from recent research!
Use of Digital Health Technologies for Dementia Care: Bibliometric Analysis and Report.
Digital health technologies are transforming dementia care. 📱🧠 Our review highlights key research trends and knowledge gaps.
Precision oncology through next generation sequencing in hepatocellular carcinoma.
Next-Generation Sequencing enhances precision medicine in hepatocellular carcinoma, addressing drug resistance and improving treatment outcomes. 🧬🔬
Comparative performance of multiple ensemble learning models for preoperative prediction of tumor deposits in rectal cancer based on MR imaging.
Ensemble learning models show promise in predicting tumor deposits in rectal cancer. 🩺📊 VELM outperforms others with an AUC of 0.875.
Women Entrepreneurs Shine at UK Women in Innovation Awards
Women entrepreneurs excelled at the UK Women in Innovation Awards, showcasing innovative health tech solutions. 🏆💡